These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34885027)

  • 21. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
    Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
    J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
    Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW
    Breast; 2012 Feb; 21(1):50-7. PubMed ID: 21865043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
    Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
    BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
    Weitzenfeld P; Meshel T; Ben-Baruch A
    Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells.
    Singh S; Chakrabarti R
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31075939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers.
    Kim S; Moon BI; Lim W; Park S; Cho MS; Sung SH
    Clin Breast Cancer; 2018 Oct; 18(5):e1123-e1132. PubMed ID: 29754847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions.
    Lee KL; Chen G; Chen TY; Kuo YC; Su YK
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
    Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
    Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor infiltrating CD8
    Mella M; Kauppila JH; Karihtala P; Lehenkari P; Jukkola-Vuorinen A; Soini Y; Auvinen P; Vaarala MH; Ronkainen H; Kauppila S; Haapasaari KM; Vuopala KS; Selander KS
    Oncoimmunology; 2015 Jun; 4(6):e1002726. PubMed ID: 26155410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies.
    Ferreira Almeida C; Correia-da-Silva G; Teixeira N; Amaral C
    Biochem Pharmacol; 2024 May; 223():116178. PubMed ID: 38561089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes].
    Zhang T; Li Q; Xu B; Zhang P; Yuan P; Ma F; Wang J; Fan Y
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):697-702. PubMed ID: 25564062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of breast cancer subtypes and patterns of metastasis on outcome.
    Kast K; Link T; Friedrich K; Petzold A; Niedostatek A; Schoffer O; Werner C; Klug SJ; Werner A; Gatzweiler A; Richter B; Baretton G; Wimberger P
    Breast Cancer Res Treat; 2015 Apr; 150(3):621-9. PubMed ID: 25783184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya.
    Sawe RT; Mining SK; Ofulla AV; Patel K; Guyah B; Chumba D; Prosperi JR; Kerper M; Shi Z; Sandoval-Cooper M; Taylor K; Badve S; Stack MS; Littlepage LE
    Trop Med Health; 2017; 45():19. PubMed ID: 28794686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation.
    Zheng H; Siddharth S; Parida S; Wu X; Sharma D
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database.
    Kim YJ; Kim JS; Kim IA
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1803-1816. PubMed ID: 29971531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies.
    Zarrilli G; Businello G; Dieci MV; Paccagnella S; Carraro V; Cappellesso R; Miglietta F; Griguolo G; Guarneri V; Lo Mele M; Fassan M
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.